Thrombolysis for ischaemic stroke despite direct oral anticoagulation.

Purrucker, Jan C; Meinel, Thomas R; Wilson, Duncan; Xian, Ying; Wu, Teddy Y; Seiffge, David J (2024). Thrombolysis for ischaemic stroke despite direct oral anticoagulation. (In Press). Stroke and vascular neurology BMJ 10.1136/svn-2023-002727

[img]
Preview
Text
svn-2023-002727.full.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (381kB) | Preview

Intravenous thrombolysis is not recommended in anticoagulated patients receiving direct oral anticoagulants (DOACs) and a recent intake within the last 48 hours in US and European guidelines. However, three observational studies now suggest safety of thrombolysis in patients with recent intake of DOACs, and thus support previous experimental data. In this perspective, the current evidence and practical consequences are discussed.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Meinel, Thomas Raphael, Seiffge, David Julian

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2059-8696

Publisher:

BMJ

Language:

English

Submitter:

Pubmed Import

Date Deposited:

01 Feb 2024 14:39

Last Modified:

02 Feb 2024 05:58

Publisher DOI:

10.1136/svn-2023-002727

PubMed ID:

38296587

Uncontrolled Keywords:

Anticoagulants Stroke Thrombolysis

BORIS DOI:

10.48350/192320

URI:

https://boris.unibe.ch/id/eprint/192320

Actions (login required)

Edit item Edit item
Provide Feedback